Juvéderm Ultra XC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Juvéderm Ultra XC, covering 2015-09-02 to 2018-03-26. Get the full timeline:
Most recent: Clinical Trial Update: TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds [NA]